{"id":793459,"date":"2024-12-09T11:03:12","date_gmt":"2024-12-09T16:03:12","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\/"},"modified":"2024-12-09T11:03:12","modified_gmt":"2024-12-09T16:03:12","slug":"dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\/","title":{"rendered":"Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences\u2019 Scientific Advisory Board"},"content":{"rendered":"<h2>\nKlotho Neurosciences, Inc. continues to strengthen its advisory teams with recent new additions of Neuroscience and Big Pharma leaders to Scientific Advisory Board and Board of Directors<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"left\">NEW YORK, Dec.  09, 2024  (GLOBE NEWSWIRE) &#8212; Klotho Neurosciences, Inc. (NASDAQ: <strong>KLTO<\/strong>), a specialty biotechnology company focused on developing cell and gene therapies for amyotrophic lateral sclerosis (ALS), Alzheimer\u2019s and Parkinson\u2019s disease is proud to announce the appointment of Dr. Merit Cudkowicz, MD, MSc, to its Scientific Advisory Board (SAB).<\/p>\n<p>Dr. Cudkowicz is the Chair of Neurology at MGH, Director of the Sean M. Healey &amp; AMG Center for ALS, and is the Julieanne Dorn Professor of Neurology at Harvard Medical School. A member of the National Academy of Medicine, Dr. Cudkowicz has been a leading clinician in promoting and devising more efficient methods for the development of therapies for people with neurological disorders such as ALS. She is one of the founders and co-directors of the Northeast ALS (NEALS) Consortium, a group of over 150 clinical sites in the United States and Canada dedicated to performing collaborative, academic-led clinical trials in ALS subjects.<\/p>\n<p>In welcoming Dr. Cudkowicz to the SAB, Dr. Joseph Sinkule, the Founder, CEO, and Chairman of Klotho Neurosciences commented: \u201cDr. Cudkowicz is clearly a world-renowned clinician and authority in the field of ALS, which is also often referred to as Lou Gehrig&#8217;s disease. We are honored to have her join our SAB and help guide us in clinical trial design and execution. We firmly believe that the Company\u2019s gene therapy approach could be an important advance in the treatment of ALS using our patent-protected product candidate expressing the Klotho gene transcribed protein called \u2018s-KL\u2019 or \u201csecreted Klotho.\u201d<\/p>\n<p>In responding, Dr. Cudkowicz expressed her appreciation for the invitation to join the SAB, stating that \u201cIt is vitally important that a company like Klotho Neurosciences receives the full support and guidance from members of their SAB to maximize the opportunity to expeditiously develop a safe and effective new treatment for ALS based on the Company\u2019s proprietary s-KL. There is a clear and absolute urgent need for new and effective treatments for this devastating, universally-fatal disease, and I hope to be able to assist Klotho Neurosciences along the path to success.\u201d<\/p>\n<p>\n        <strong>About Klotho Neurosciences, Inc.<\/strong>\n      <\/p>\n<p>Klotho Neurosciences, Inc. (NASDAQ: KLTO), is a biopharmaceutical company focused on the development of innovative, disease-modifying cell and gene therapies using a protein derived from a patented form of the \u201canti-aging\u201d human Klotho gene and it\u2019s novel delivery system (s-KL\/AAV.myo) to transform and improve the treatment of neurodegenerative and age-related disorders such as ALS, Alzheimer&#8217;s, and Parkinson&#8217;s disease. The company\u2019s current portfolio consists of its proprietary cell and gene therapy programs using DNA and RNA as therapeutics and genomics-based diagnostics. Other assets include clinical-stage programs involving antibody biologics targeting cancer and autoimmune diseases, and drug delivery via a needle-free dry powder jet autoinjector called Nanoject. The company is managed by a team of individuals and advisors who are highly experienced in biopharmaceutical product development and commercialization.<\/p>\n<p>\n        <strong>For more information, contact:<\/strong>\n      <\/p>\n<p>Eric Boyd<\/p>\n<p>Investor Relations<\/p>\n<p>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5wOgbfpud7Gk--UC1dbd_P445MkJ85Gg8eGTPqMUEcX2or5gk_YHfoAdr9p5kPyGJndT9hnx5eW1HUqDVwgUQ6saGgpbSJOu26pHPyMIJwQ=\" rel=\"nofollow\" target=\"_blank\">IR@klothoneuro.com<\/a><\/p>\n<p>Website: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=C_kf9jz5A4yDmyFJ7xcVTh5QMKFXrb8_DBPKAVDdxNLfi36vBXLAj-ADKkFL8PuYG1bLiHgCu3FLMmLWArVgzMz3m4w8Qo_FEpY8eKdSUVU=\" rel=\"nofollow\" target=\"_blank\">www.klothoneuro.com<\/a><\/p>\n<p>\n        <strong>Forward-Looking Statements:<\/strong>\n      <\/p>\n<p>This press release contains forward-looking statements. These statements are made under the \u201csafe harbor\u201d provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements generally are identified by the words \u201cbelieve,\u201d \u201cproject,\u201d \u201cexpect,\u201d \u201canticipate,\u201d \u201cestimate,\u201d \u201cintend,\u201d \u201cstrategy,\u201d \u201cfuture,\u201d \u201copportunity,\u201d \u201cplan,\u201d \u201cmay,\u201d \u201cshould,\u201d \u201cwill,\u201d \u201cwould,\u201d \u201cwill be,\u201d \u201cwill continue,\u201d \u201cwill likely result,\u201d and similar expressions. Without limiting the generality of the foregoing, the forward-looking statements in this press release include descriptions of the Company\u2019s future commercial operations. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, such as the Company\u2019s inability to implement its business plans, identify and realize additional opportunities, or meet or exceed its financial projections and changes in the regulatory or competitive environment in which the Company operates. You should carefully consider the foregoing factors and the other risks and uncertainties described in the documents filed or to be filed by the Company with the U.S. Securities and Exchange Commission (the \u201cSEC\u201d) from time to time, which could cause actual events and results to differ materially from those contained in the forward-looking statements. Copies of these documents are available on the SEC\u2019s website, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Wqmeod8Gtl_llU3dr2vkjs48GirDdWkqb98c3fcdhDiSHMSU5TS7NFW8OLmkzhQXH_NWhLIwhqvLmj1gT8gWQg==\" rel=\"nofollow\" target=\"_blank\">www.sec.gov<\/a>. All information provided herein is as of the date of this press release, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxNTk0OSM2NjI4MDcwIzUwMDEyODUzNw==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/Mzk1Y2Y2MTItZWFiMS00MDU5LTk3ZDEtNWIyNDczZThmOTZmLTUwMDEyODUzNw==\/tiny\/Klotho-Neurosciences-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Klotho Neurosciences, Inc. continues to strengthen its advisory teams with recent new additions of Neuroscience and Big Pharma leaders to Scientific Advisory Board and Board of Directors NEW YORK, Dec. 09, 2024 (GLOBE NEWSWIRE) &#8212; Klotho Neurosciences, Inc. (NASDAQ: KLTO), a specialty biotechnology company focused on developing cell and gene therapies for amyotrophic lateral sclerosis (ALS), Alzheimer\u2019s and Parkinson\u2019s disease is proud to announce the appointment of Dr. Merit Cudkowicz, MD, MSc, to its Scientific Advisory Board (SAB). Dr. Cudkowicz is the Chair of Neurology at MGH, Director of the Sean M. Healey &amp; AMG Center for ALS, and is the Julieanne Dorn Professor of Neurology at Harvard Medical School. A member of the National Academy of Medicine, Dr. Cudkowicz &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences\u2019 Scientific Advisory Board&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-793459","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences\u2019 Scientific Advisory Board - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences\u2019 Scientific Advisory Board - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Klotho Neurosciences, Inc. continues to strengthen its advisory teams with recent new additions of Neuroscience and Big Pharma leaders to Scientific Advisory Board and Board of Directors NEW YORK, Dec. 09, 2024 (GLOBE NEWSWIRE) &#8212; Klotho Neurosciences, Inc. (NASDAQ: KLTO), a specialty biotechnology company focused on developing cell and gene therapies for amyotrophic lateral sclerosis (ALS), Alzheimer\u2019s and Parkinson\u2019s disease is proud to announce the appointment of Dr. Merit Cudkowicz, MD, MSc, to its Scientific Advisory Board (SAB). Dr. Cudkowicz is the Chair of Neurology at MGH, Director of the Sean M. Healey &amp; AMG Center for ALS, and is the Julieanne Dorn Professor of Neurology at Harvard Medical School. A member of the National Academy of Medicine, Dr. Cudkowicz &hellip; Continue reading &quot;Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences\u2019 Scientific Advisory Board&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-09T16:03:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxNTk0OSM2NjI4MDcwIzUwMDEyODUzNw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences\u2019 Scientific Advisory Board\",\"datePublished\":\"2024-12-09T16:03:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\\\/\"},\"wordCount\":804,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxNTk0OSM2NjI4MDcwIzUwMDEyODUzNw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\\\/\",\"name\":\"Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences\u2019 Scientific Advisory Board - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxNTk0OSM2NjI4MDcwIzUwMDEyODUzNw==\",\"datePublished\":\"2024-12-09T16:03:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxNTk0OSM2NjI4MDcwIzUwMDEyODUzNw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTMxNTk0OSM2NjI4MDcwIzUwMDEyODUzNw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences\u2019 Scientific Advisory Board\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences\u2019 Scientific Advisory Board - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\/","og_locale":"en_US","og_type":"article","og_title":"Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences\u2019 Scientific Advisory Board - Market Newsdesk","og_description":"Klotho Neurosciences, Inc. continues to strengthen its advisory teams with recent new additions of Neuroscience and Big Pharma leaders to Scientific Advisory Board and Board of Directors NEW YORK, Dec. 09, 2024 (GLOBE NEWSWIRE) &#8212; Klotho Neurosciences, Inc. (NASDAQ: KLTO), a specialty biotechnology company focused on developing cell and gene therapies for amyotrophic lateral sclerosis (ALS), Alzheimer\u2019s and Parkinson\u2019s disease is proud to announce the appointment of Dr. Merit Cudkowicz, MD, MSc, to its Scientific Advisory Board (SAB). Dr. Cudkowicz is the Chair of Neurology at MGH, Director of the Sean M. Healey &amp; AMG Center for ALS, and is the Julieanne Dorn Professor of Neurology at Harvard Medical School. A member of the National Academy of Medicine, Dr. Cudkowicz &hellip; Continue reading \"Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences\u2019 Scientific Advisory Board\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\/","og_site_name":"Market Newsdesk","article_published_time":"2024-12-09T16:03:12+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxNTk0OSM2NjI4MDcwIzUwMDEyODUzNw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences\u2019 Scientific Advisory Board","datePublished":"2024-12-09T16:03:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\/"},"wordCount":804,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxNTk0OSM2NjI4MDcwIzUwMDEyODUzNw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\/","name":"Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences\u2019 Scientific Advisory Board - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxNTk0OSM2NjI4MDcwIzUwMDEyODUzNw==","datePublished":"2024-12-09T16:03:12+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxNTk0OSM2NjI4MDcwIzUwMDEyODUzNw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTMxNTk0OSM2NjI4MDcwIzUwMDEyODUzNw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-merit-cudkowicz-renowned-als-expert-at-massachusetts-general-hospital-mgh-joins-klotho-neurosciences-scientific-advisory-board\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences\u2019 Scientific Advisory Board"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/793459","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=793459"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/793459\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=793459"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=793459"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=793459"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}